Damir Simic
Takeda (United States)(US)Vital Therapies (United States)(US)
Publications by Year
Research Areas
Mitochondrial Function and Pathology, Pharmacogenetics and Drug Metabolism, Liver physiology and pathology, Metabolism and Genetic Disorders, 3D Printing in Biomedical Research
Most-Cited Works
- → Reproducing human and cross-species drug toxicities using a Liver-Chip(2019)455 cited
- → Organ‐on‐Chip Recapitulates Thrombosis Induced by an anti‐CD154 Monoclonal Antibody: Translational Potential of Advanced Microengineered Systems(2018)131 cited
- → Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury(2017)81 cited
- → The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity(2018)42 cited
- → Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model(2016)26 cited
- → Acute Metabolic Switch Assay Using Glucose/Galactose Medium in HepaRG Cells to Detect Mitochondrial Toxicity(2019)22 cited
- → Effects of BMS-986094, a Guanosine Nucleotide Analogue, on Mitochondrial DNA Synthesis and Function(2016)14 cited
- → In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension(2017)14 cited
- → Investigating Cytoskeletal Alterations as a Potential Marker of Retinal and Lens Drug-Related Toxicity(2006)13 cited
- → Blocking α5β1 Integrin Attenuates sCD40L-Mediated Platelet Activation(2015)12 cited